Mirikizumab is safe and effective in patients with moderate-to-severe Crohn’s disease
1. The composite of patient-reported clinical response and endoscopic response was significantly greater in mirikizumab versus placebo. 2. Clinical remission ...
Tag: Mirikizumab
Mirikizumab induces clinical remission in patients with ulcerative colitis
1. In this randomized controlled trial, patients with ulcerative colitis taking mirikizumab had higher rates of clinical remission compared to ...
#VisualAbstract: Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be ...